Cargando…
Efficacy of a Bicistronic Vector for Correction of Sandhoff Disease in a Mouse Model
G(M2) gangliosidoses are a family of severe neurodegenerative disorders resulting from a deficiency in the β-hexosaminidase A enzyme. These disorders include Tay-Sachs disease and Sandhoff disease, caused by mutations in the HEXA gene and HEXB gene, respectively. The HEXA and HEXB genes are required...
Autores principales: | Woodley, Evan, Osmon, Karlaina J.L., Thompson, Patrick, Richmond, Christopher, Chen, Zhilin, Gray, Steven J., Walia, Jagdeep S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279944/ https://www.ncbi.nlm.nih.gov/pubmed/30534578 http://dx.doi.org/10.1016/j.omtm.2018.10.011 |
Ejemplares similares
-
Investigating Immune Responses to the scAAV9-HEXM Gene Therapy Treatment in Tay–Sachs Disease and Sandhoff Disease Mouse Models
por: Kot, Shalini, et al.
Publicado: (2021) -
Gene Expression Profile in the Sandhoff Mouse Brain with Progression of Age
por: Singh, Kshitiz, et al.
Publicado: (2022) -
Efficacy of Adeno-Associated Virus Serotype 9-Mediated Gene Therapy for AB-Variant GM2 Gangliosidosis
por: Vyas, Meera, et al.
Publicado: (2023) -
Long term expression of bicistronic vector driven by the FGF-1 IRES in mouse muscle
por: Allera-Moreau, Camille, et al.
Publicado: (2007) -
Development of a new bicistronic retroviral vector with strong IRES activity
por: Martin, Patrick, et al.
Publicado: (2006)